Featured

Dr. Jumper’s work with AlphaFold2 represents an unprecedented step in the integration of artificial intelligence and the natural sciences. John and his colleagues have given us inspiring evidence of its limitless potential for advancing scientific discovery. Read More

Calipari wins award for transforming scientists’ understanding of how behavioral circuits are dysregulated by long-term drug use and for her commitment to train and support the next generation of addiction scientists. Read More

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra’s platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules Read More

Christian de Caestecker, a Ph.D. student in the lab of Ian Macara, Louise B. McGavock Professor and chair of the Department of Cell and Developmental Biology, proposed and validated a mechanism that solved a decades-old mystery: he shed light on the process by which epithelial cells, polarized cells that face the outside world, sort and deliver the specialized proteins they need at each cell’s poles. Read More

Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read More